Search

everythinglearnresearchcommunity

for

Search:↓

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Sebaceous glands can help harvest hair follicle stem cells to regenerate skin and hair.

Ellis van Creveld syndrome, a rare genetic disorder, can cause unexpected abnormalities in various body organs, requiring thorough patient evaluations.

Clofazimine effectively treated a rare skin condition with ash-gray patches.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

SOX9 helps determine stem cell roles by interacting with DNA and proteins that control gene activity.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Most cases of Temporal Triangular Alopecia are found in early childhood and may be related to genetic conditions.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Keratin 26 affects cashmere goat hair growth and is influenced by various treatments.

Over half of the children had abnormal hair under a microscope, with many having genetic hair conditions.

Hair follicles in the back of the rosette fancy mouse have reversed orientations due to a gene mutation.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.